Literature DB >> 30167832

Immunotherapy for bladder cancer: the fight is on.

Morgan Rouprêt1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30167832     DOI： 10.1007/s00345-018-2468-3

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  16 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Molecularly-driven precision medicine for advanced bladder cancer.

Authors:  Laura-Maria Krabbe; Vitaly Margulis; Andres Jan Schrader; Shahrokh F Shariat; Kilian M Gust; Martin Boegemann
Journal:  World J Urol       Date:  2018-06-08       Impact factor: 4.226

3.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

Review 4.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard J Sylvester; Maximilian Burger; Nigel C Cowan; Paolo Gontero; Bas W G Van Rhijn; A Hugh Mostafid; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2017-09-01       Impact factor: 20.096

5.  Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.

Authors:  Kees Hendricksen; Atiqullah Aziz; Perrine Bes; Felix K-H Chun; Jakub Dobruch; Luis A Kluth; Paolo Gontero; Andrea Necchi; Aidan P Noon; Bas W G van Rhijn; Michael Rink; Florian Roghmann; Morgan Rouprêt; Roland Seiler; Shahrokh F Shariat; Brian Qvick; Marek Babjuk; Evanguelos Xylinas
Journal:  Eur Urol Focus       Date:  2017-10-23

6.  Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.

Authors:  Ashish M Kamat; Roger Li; Michael A O'Donnell; Peter C Black; Morgan Roupret; James W Catto; Eva Comperat; Molly A Ingersoll; Wim P Witjes; David J McConkey; J Alfred Witjes
Journal:  Eur Urol       Date:  2017-10-18       Impact factor: 20.096

7.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Authors:  J Alfred Witjes; Thierry Lebret; Eva M Compérat; Nigel C Cowan; Maria De Santis; Harman Maxim Bruins; Virginia Hernández; Estefania Linares Espinós; James Dunn; Mathieu Rouanne; Yann Neuzillet; Erik Veskimäe; Antoine G van der Heijden; Georgios Gakis; Maria J Ribal
Journal:  Eur Urol       Date:  2016-06-30       Impact factor: 20.096

8.  Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.

Authors:  François Audenet; Adam M Farkas; Harry Anastos; Matthew D Galsky; Nina Bhardwaj; John P Sfakianos
Journal:  World J Urol       Date:  2018-06-02       Impact factor: 4.226

9.  Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer.

Authors:  Francesco Soria; Andrea I Beleni; David D'Andrea; Irene Resch; Kilian M Gust; Paolo Gontero; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-03-16       Impact factor: 4.226

10.  A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.

Authors:  Johannes Falke; Christina A Hulsbergen-van de Kaa; Roberto Maj; Egbert Oosterwijk; J Alfred Witjes
Journal:  World J Urol       Date:  2018-05-16       Impact factor: 4.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.